Our dedicated patient engagement team, comprising Chris Dodd, Erik Farish, and Sairah Yassir-Deane, had an enriching experience at the ‘Management in Practice’ event in Manchester. We had the opportunity to interact with numerous General Practitioners (GPs) from across the UK, who are keen to introduce the concept of patient engagement in clinical research to their …
Panthera finds quality patients fast Since its launch in 2019 Panthera has concentrated on building access to patients. Today Panthera has not only access to the largest qualified patient pool in the UK – NHS or SMO – but has also built a network of GP practices including some of the leading mega GP practices providing …
Dr Ian Smith (Co-founder, Director and Chief Medical Officer) and Chris Dodd (Chief Commercial Officer) recently spoke to Jo Shorthouse at In Vivo to discuss the practicalities and reality of running clinical trial sites as a business, the efficiencies found with the SMO model, the challenge of patient recruitment as well as the decentralized and hybridized trial model. To listen to the …
The independent Site Management Organisations (SMOs) which run clinical trials on behalf of the pharmaceutical industry continue to expand not only the number of trials being brought to the UK but also the number of patients enrolled.
New data show that the site management model reduces start-up times for a Phase II or Phase III clinical trial by up to nine months compared to UK public sites, representing billions in savings Panthera identifies likely patients seven months before public sector sites start planning their recruitment campaigns. The loss of nine months patent …
